MR编号 | DE/H/5542/005 |
---|
药品名称 | Paliperidon-ratiopharm 150 mg Depot-Injektionssuspension |
---|
活性成分 | - Paliperidone palmitate 234.0 mg
|
---|
剂型 | Prolonged-release suspension for injection |
---|
上市许可持有人 | ratiopharm GmbH
Graf-Arco-Str. 3
89079 Ulm
Germany |
---|
参考成员国 - 产品名称 | Germany (DE) Paliperidon-ratiopharm 150 mg Depot-Injektionssuspension |
---|
互认成员国 - 产品名称 | - Ireland (IE)
- Sweden (SE)
- Belgium (BE)
- Iceland (IS)
- Slovenia (SI)
- Bulgaria (BG)
- Italy (IT)
- Slovakia (SK)
- Cyprus (CY)
Paliperidone/Teva 150mg Prolonged-release suspension for injection - Lithuania (LT)
- Estonia (EE)
- Luxembourg (LU)
- Spain (ES)
- Greece (GR)
- Latvia (LV)
- Netherlands (NL)
- Finland (FI)
- Norway (NO)
- France (FR)
- Poland (PL)
Paliperidone Teva - Portugal (PT)
- Denmark (DK)
- United Kingdom (Northern Ireland) (XI)
- Hungary (HU)
PALIPERIDON TEVA 150 mg retard szuszpenziós injekció - Croatia (HR)
- Romania (RO)
Paliperidonă Teva 150 mg suspensie injectabilă cu eliberare prelungită - Austria (AT)
|
---|
许可日期 | 2019/07/17 |
---|
最近更新日期 | 2024/10/22 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|